These milestones highlight the growing regulatory and clinical momentum supporting expanded uses Ongoing trials are also exploring the impact of GLP-1 agonists on cardiovascular outcomes, liver health, and even neurodegenerative diseases, reinforcing their value in treating systemic metabolic disorders
they are what gives your face its shape
Am I comfortable with potential side effects
January is the perfect time to reset, refocus, and explore the tools available to support meaningful, sustainable progress
Since the most effective current medication (tirzepatide) is only expected to give about a 21% weight loss, those with higher BMIs, may want to consider bariatric surgery as an option
Also watch for reduced effectiveness at your usual dose, which may indicate potency loss